在固体瘤微环境中优化CAR-T细胞功能:从培养介质添加剂的见解
Wenwen Chen1, Luxia Xu1, Zhigang Guo1
1Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China.
Current research in translational medicine
|January 11, 2025
概括
化学抗原受体 (CAR) -T细胞疗法在固体瘤中显示出前景. 使用特定添加剂优化细胞培养基可以增强CAR-T细胞的功能和持久性,克服瘤微环境的挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 化学抗原受体 (CAR) -T细胞疗法对血液癌症有效.
- 固体瘤存在挑战,因为免疫抑制的微环境会导致CAR-T细胞耗尽.
- 优化CAR-T细胞制造对于固体瘤治疗疗效至关重要.
研究的目的:
- 对增强CAR-T细胞表型和抗瘤功效的培养基添加剂进行审查.
- 探索添加剂减轻疲劳并改善固体瘤持续性的机制.
- 为改善固体瘤中CAR-T细胞治疗的新策略提供见解.
主要方法:
- 对研究研究培养基添加剂用于CAR-T细胞治疗的文献综述.
- 对各种添加剂的作用机制的分析.
- 评估添加剂对CAR-T细胞功能和抗瘤活性的影响.
主要成果:
- 特定培养介质添加剂在调节CAR-T细胞行为方面表现有前途.
- 添加剂可以帮助缓解瘤微环境中的CAR-T细胞耗尽.
- 通过优化介质观察到增强的CAR-T细胞持久性和抗瘤功效.
结论:
- 培养介质优化是提高固体瘤CAR-T细胞治疗的关键策略.
- 有针对性的添加剂可以克服免疫抑制瘤微环境.
- 对媒体添加剂的进一步研究有可能改善癌症患者的治疗结果.
相关概念视频
Tumor Immunotherapy
469
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
469
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K


